Lingwei Jin
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in ⓘ
- Nephrology 11
- Renal Diseases and Glomerulopathies 7
- Chronic Kidney Disease and Diabetes 4
- Parathyroid Disorders and Treatments 2
- Acute Kidney Injury Research 2
-
- Phagocytosis and Immune Regulation 2
- Co-authors
- Zhihong Zhou (5 shared papers)Yan Chen (3 shared papers)Min Pan (7 shared papers)Jian Jin (1 shared paper)Yu Zheng (3 shared papers)Xiaoyan Xu (2 shared papers)Wenwen Huang (3 shared papers)Yu Zheng (2 shared papers)
- Journals
- BMC Nephrology (2 papers)AAPS PharmSciTech (1 paper)Cell Death and Disease (1 paper)Nature Communications (1 paper)Kidney & Blood Pressure Research (1 paper)
- Partner nations
- China
In The Last Decade
Lingwei Jin
20 papers receiving 400 citations
Peers
Comparison fields: 5 of 84
- Nephrology 165
- Cancer Research 68
- Immunology 84
- Pharmacology 21
- Molecular Biology 150
Countries citing papers authored by Lingwei Jin
This map shows the geographic impact of Lingwei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingwei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingwei Jin more than expected).
Fields of papers citing papers by Lingwei Jin
This network shows the impact of papers produced by Lingwei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingwei Jin. The network helps show where Lingwei Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingwei Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 82 | |
| 2 | 2019 | 74 | |
| 3 | 2018 | 43 | |
| 4 | 2016 | 33 | |
| 5 | 2017 | 26 | |
| 6 | 2018 | 21 | |
| 7 | Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis. | 2018 | 19 |
| 8 | 2021 | 18 | |
| 9 | Elevated serum interleukin-35 levels correlate with poor prognosis in patients with clear cell renal cell carcinoma. | 2015 | 17 |
| 10 | 2015 | 15 | |
| 11 | 2020 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2020 | 9 | |
| 14 | 2019 | 8 | |
| 15 | 2023 | 4 | |
| 16 | 2019 | 3 | |
| 17 | 2018 | 3 | |
| 18 | 2024 | 2 | |
| 19 | Decreased expression of miR-495 is associated with poor prognosis in clear cell renal cell carcinoma | 2017 | 1 |
| 20 | 2017 | 1 |
About Lingwei Jin
Lingwei Jin is a scholar working on Nephrology, Immunology, Pulmonary and Respiratory Medicine, Molecular Medicine and Cancer Research, having authored 21 papers that have together received 402 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (7 papers), Chronic Kidney Disease and Diabetes (4 papers), Kruppel-like factors research (3 papers), Phagocytosis and Immune Regulation (2 papers), Renal and related cancers (2 papers), Parathyroid Disorders and Treatments (2 papers), Acute Kidney Injury Research (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Nephrology (165 citations), Cancer Research (68 citations), Immunology (84 citations), Pharmacology (21 citations) and Molecular Biology (150 citations). Lingwei Jin has collaborated with scholars based in China. Frequent co-authors include Zhihong Zhou, Yan Chen, Min Pan, Jian Jin, Yu Zheng, Xiaoyan Xu, Wenwen Huang, Yu Zheng, Zhanmei Zhou and Li‐Ling Wu. Their work appears in journals such as BMC Nephrology, AAPS PharmSciTech, Cell Death and Disease, Nature Communications and Kidney & Blood Pressure Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.